
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 6.10687022901 | 1.31 | 1.51 | 1.25 | 163620 | 1.36012298 | CS |
4 | 0.43 | 44.7916666667 | 0.96 | 1.51 | 0.8502 | 1233715 | 1.33511796 | CS |
12 | 0.31 | 28.7037037037 | 1.08 | 1.51 | 0.8502 | 499126 | 1.29187187 | CS |
26 | -0.36 | -20.5714285714 | 1.75 | 2.093 | 0.8502 | 259780 | 1.34361589 | CS |
52 | -0.96 | -40.8510638298 | 2.35 | 4.21 | 0.8502 | 195307 | 1.8342105 | CS |
156 | -3.09 | -68.9732142857 | 4.48 | 7.38 | 0.8502 | 342721 | 2.8735187 | CS |
260 | -10.09 | -87.8919860627 | 11.48 | 17.2 | 0.8502 | 277223 | 3.26295505 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales